60 Yoshino S, Tagawa T, Awa R, Ogasawara J, Kuwahara H, Fukuhara I
Furthermore, it could be shown that DPP4 inhibition is clearly associated with significantly increased -cell mass and function in several models of T2DM (134136)
[Google Scholar] 96
(Table 3 in the article lists common GLP-1 drugs' half-lives and withhold times.) New Research Supports Continuing GLP-1 Meds Before Surgery Stanford researchers suggest that a less conservative approach might be appropriate for both type 2 diabetes and obesity patients
Sublingual GLP-1 drops: what the science actually says EllieMD promotes its sublingual drops as a convenient, needle-free alternative to weekly injections
2025, 10:10.13140/RG.2.2.31931.84007 Abd Rahim NH, Ming LC, Ali Al-Worafi YM, Sarker MR: A regulatory review for products containing glutathione